Trial Site Detail

 

Drug:
Olaratumab (IMC-3G3)
Trial:
A Study of IMC-3G3 in Previously Treated Patients With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Southwest German Cancer Center at Eberhard-Karls University

     
Tuebingen , D-72076
Germany

 

Principal Investigator:
 Joerg T. Hartmann, MD
Contact:
 49-707-1298-2127 joerg.hartmann@med.uni-tuebingen.de
Activation Status of this Site:
 Closed
Notes about this Site:
Southwest German Cancer Center at Eberhard-Karls University Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.